Combination antithyroid agents and supplements

Pseudothymidine is a C-nucleoside analog of thymidine.In VitroPseudothymidine is a C-nucleoside analog of thymidine. The calculated ΔΔG° 50 /mod is -0.5 kcal/mol, with a Δ T m /mod of 0.82°C. For the duplexes containing nine dA-T/ψT pairs, the Δ T m

Species : Rat Assay Principle : Target Name : parathyroid hormone 1-34 Sensitivity : Detection Range :

Species : Rat Assay Principle : Quantitative Target Name : Parathyroid hormone Sensitivity : 0.5 pg/ml Detection Range : 2 pg/ml-150 pg/ml

TSHR antagonist S37a is a highly selective thyrotropin receptor (TSHR) antagonist, with potential for the treatment of Graves' orbitopathyIn VitroTSHR antagonist S37a exhibits inhibition activity for TSHR, with IC 50 s of 40 µM and approximately 20

TSHR antagonist S37a is a highly selective thyrotropin receptor (TSHR) antagonist, with potential for the treatment of Graves' orbitopathyIn VitroTSHR antagonist S37a exhibits inhibition activity for TSHR, with IC 50 s of 40 µM and approximately 20

TSHR antagonist S37a is a highly selective thyrotropin receptor (TSHR) antagonist, with potential for the treatment of Graves' orbitopathyIn VitroTSHR antagonist S37a exhibits inhibition activity for TSHR, with IC 50 s of 40 µM and approximately 20

TSHR antagonist S37a is a highly selective thyrotropin receptor (TSHR) antagonist, with potential for the treatment of Graves' orbitopathyIn VitroTSHR antagonist S37a exhibits inhibition activity for TSHR, with IC 50 s of 40 µM and approximately 20

TSHR antagonist S37a is a highly selective thyrotropin receptor (TSHR) antagonist, with potential for the treatment of Graves' orbitopathyIn VitroTSHR antagonist S37a exhibits inhibition activity for TSHR, with IC 50 s of 40 µM and approximately 20

TSHR antagonist S37a is a highly selective thyrotropin receptor (TSHR) antagonist, with potential for the treatment of Graves' orbitopathyIn VitroTSHR antagonist S37a exhibits inhibition activity for TSHR, with IC 50 s of 40 µM and approximately 20

Cell Line Origin Human Caucasian thyroid medullary carcinoma Cell Line Description Established from a thyroid medullary carcinoma of a 77 year old Caucasian female. Tumourigenic in nude mice.